{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:49:26Z","timestamp":1789102166849,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01189-w","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T09:20:32Z","timestamp":1741598432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia\u2019s drug supply"],"prefix":"10.1186","volume":"22","author":[{"given":"Bruce","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Shkolnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Kielty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Gozdzialski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Jai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Margolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Gonzalez-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Saatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Abruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taelor","family":"Zarkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Hore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u2018heroin\u2019. Int J Drug Policy. 2017;46:146\u201355.","journal-title":"Int J Drug Policy"},{"issue":"10324","key":"1189_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","volume":"399","author":"K Humphreys","year":"2022","unstructured":"Humphreys K, Shover CL, Andrews CM, Bohnert AS, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford\u2013Lancet commission. Lancet. 2022;399(10324):555\u2013604.","journal-title":"Lancet"},{"key":"1189_CR3","unstructured":"BC Coroners Service. BC Coroners Service Death Review Panel: An Urgent Response to a Continuing Crisis. 2023."},{"issue":"1","key":"1189_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12954-023-00782-1","volume":"20","author":"R Daniulaityte","year":"2023","unstructured":"Daniulaityte R, Ruhter L, Juhascik M, Silverstein S. Attitudes and experiences with Fentanyl contamination of methamphetamine: exploring self-reports and urine toxicology among persons who use methamphetamine and other drugs. Harm Reduct J. 2023;20(1):54.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1189_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12954-019-0351-1","volume":"17","author":"T Fleming","year":"2020","unstructured":"Fleming T, Barker A, Ivsins A, Vakharia S, McNeil R. Stimulant safe supply: a potential opportunity to respond to the overdose epidemic. Harm Reduct J. 2020;17(1):6.","journal-title":"Harm Reduct J"},{"issue":"1suppl","key":"1189_CR6","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1177\/00333549211012407","volume":"136","author":"L Lasher","year":"2021","unstructured":"Lasher L, Hallowell BD, Chambers LC, Koziol J, McDonald J, Elmaleh R, et al. Using timely overdose data to address a Spike in nonfatal overdoses and inform a coordinated Community-Level response in Rhode Island, 2019. Public Health Rep. 2021;136(1suppl):S24\u201330.","journal-title":"Public Health Rep"},{"key":"1189_CR7","doi-asserted-by":"publisher","first-page":"108722","DOI":"10.1016\/j.drugalcdep.2021.108722","volume":"224","author":"T-LE Lockwood","year":"2021","unstructured":"Lockwood T-LE, Huynh P, Richard A, Sightes E, Bailey K, Ray B, et al. Community overdose surveillance: comparing substances collected from the death scene investigation to toxicology results. Drug Alcohol Depend. 2021;224:108722.","journal-title":"Drug Alcohol Depend"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"108416","DOI":"10.1016\/j.drugalcdep.2020.108416","volume":"218","author":"JN Park","year":"2021","unstructured":"Park JN, Rashidi E, Foti K, Zoorob M, Sherman S, Alexander GC. Fentanyl and Fentanyl analogs in the illicit stimulant supply: results from U.S. Drug seizure data, 2011\u20132016. Drug Alcohol Depend. 2021;218:108416.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1189_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12954-022-00659-9","volume":"19","author":"SS Shin","year":"2022","unstructured":"Shin SS, LaForge K, Stack E, Pope J, Leichtling G, Larsen JE, et al. It wasn\u2019t here, and now it is. It\u2019s everywhere: Fentanyl\u2019s rising presence in Oregon\u2019s drug supply. Harm Reduct J. 2022;19(1):76.","journal-title":"Harm Reduct J"},{"key":"1189_CR10","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker NP, Owczarzak J, Urquhart G, Park JN, Rouhani S, Ling R, et al. Agency in the Fentanyl era: exploring the utility of Fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900.","journal-title":"Int J Drug Policy"},{"key":"1189_CR11","doi-asserted-by":"publisher","first-page":"103677","DOI":"10.1016\/j.drugpo.2022.103677","volume":"104","author":"A Borquez","year":"2022","unstructured":"Borquez A, Martin NK. Fatal overdose: predicting to prevent. Int J Drug Policy. 2022;104:103677.","journal-title":"Int J Drug Policy"},{"key":"1189_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.trsl.2021.03.018","volume":"234","author":"C Marks","year":"2021","unstructured":"Marks C, Carrasco-Escobar G, Carrasco-Hern\u00e1ndez R, Johnson D, Ciccarone D, Strathdee SA, et al. Methodological approaches for the prediction of opioid use-related epidemics in the united States: a narrative review and cross-disciplinary call to action. Translational Res. 2021;234:88\u2013113.","journal-title":"Translational Res"},{"issue":"6","key":"1189_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/15563650902967404","volume":"47","author":"LS Friedman","year":"2009","unstructured":"Friedman LS. Real-time surveillance of illicit drug overdoses using poison center data. Clin Toxicol. 2009;47(6):573\u20139.","journal-title":"Clin Toxicol"},{"issue":"3","key":"1189_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1108\/DHS-01-2022-0007","volume":"23","author":"MJ Barratt","year":"2022","unstructured":"Barratt MJ, Measham F. What is drug checking. anyway? Drugs Habits Social Policy. 2022;23(3):176\u201387.","journal-title":"anyway? Drugs Habits Social Policy"},{"issue":"1","key":"1189_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12954-023-00924-5","volume":"21","author":"KJ Moon","year":"2024","unstructured":"Moon KJ, Whitehead HD, Trinh A, Hasenstab KA, Hayes KL, Stanley D, et al. Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA. Harm Reduct J. 2024;21(1):11.","journal-title":"Harm Reduct J"},{"key":"1189_CR16","doi-asserted-by":"publisher","first-page":"104206","DOI":"10.1016\/j.drugpo.2023.104206","volume":"121","author":"JN Park","year":"2023","unstructured":"Park JN, Tardif J, Thompson E, Rosen JG, Lira JAS, Green TC. A survey of North American drug checking services operating in 2022. Int J Drug Policy. 2023;121:104206.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"1189_CR17","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/dta.3022","volume":"13","author":"B Wallace","year":"2021","unstructured":"Wallace B, Hills R, Rothwell J, Kumar D, Garber I, van Roode T, et al. Implementing an integrated multi-technology platform for drug checking: social, scientific, and technological considerations. Drug Test Anal. 2021;13(4):734\u201346.","journal-title":"Drug Test Anal"},{"issue":"1","key":"1189_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/dta.3520","volume":"16","author":"L Gozdzialski","year":"2024","unstructured":"Gozdzialski L, Hutchison A, Wallace B, Gill C, Hore D. Toward automated infrared spectral analysis in community drug checking. Drug Test Anal. 2024;16(1):83\u201392.","journal-title":"Drug Test Anal"},{"key":"1189_CR19","doi-asserted-by":"crossref","unstructured":"Borden SA, Saatchi A, Vandergrift GW, Palaty J, Lysyshyn M, Gill CG. A new quantitative drug checking technology for harm reduction: pilot study in Vancouver, Canada using paper spray mass spectrometry. Drug Alcohol Rev. 2021:1\u20139.","DOI":"10.1111\/dar.13370"},{"issue":"1","key":"1189_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12954-023-00764-3","volume":"20","author":"L Gozdzialski","year":"2023","unstructured":"Gozdzialski L, Wallace B, Hore D. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations. Harm Reduct J. 2023;20(1):39.","journal-title":"Harm Reduct J"},{"key":"1189_CR21","doi-asserted-by":"publisher","first-page":"103169","DOI":"10.1016\/j.drugpo.2021.103169","volume":"93","author":"MK Laing","year":"2021","unstructured":"Laing MK, Ti L, Marmel A, Tobias S, Shapiro AM, Laing R, et al. An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods. Int J Drug Policy. 2021;93:103169.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1189_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00453-5","volume":"18","author":"A Larnder","year":"2021","unstructured":"Larnder A, Burek P, Wallace B, Hore DK. Third party drug checking: accessing harm reduction services on the behalf of others. Harm Reduct J. 2021;18(1):1\u20134.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1189_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-023-00816-8","volume":"20","author":"J Ondocsin","year":"2023","unstructured":"Ondocsin J, Holm N, Mars SG, Ciccarone D. The motives and methods of methamphetamine and \u2018heroin\u2019co-use in West Virginia. Harm Reduct J. 2023;20(1):88.","journal-title":"Harm Reduct J"},{"key":"1189_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13011-021-00414-6","volume":"16","author":"S Parent","year":"2021","unstructured":"Parent S, Papamihali K, Graham B, Buxton JA. Examining prevalence and correlates of smoking opioids in British Columbia: opioids are more often smoked than injected. Subst Abuse Treat Prev Policy. 2021;16:1\u20139.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"1189_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-023-00761-6","volume":"20","author":"R Brien","year":"2023","unstructured":"Brien R, Volpe I, Grigg J, Lyons T, Hughes C, McKinnon G, et al. Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia. Harm Reduct J. 2023;20(1):30.","journal-title":"Harm Reduct J"},{"issue":"7","key":"1189_CR26","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/add.12151","volume":"108","author":"T Kerr","year":"2013","unstructured":"Kerr T, Small W, Hyshka E, Maher L, Shannon K. It\u2019s more about the heroin\u2019: injection drug users\u2019 response to an overdose warning campaign in a Canadian setting. Addiction. 2013;108(7):1270\u20136.","journal-title":"Addiction"},{"issue":"2","key":"1189_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/09581590601045220","volume":"17","author":"PG Miller","year":"2007","unstructured":"Miller PG. Media reports of heroin overdose spates: public health messages, moral panics or risk advertisements? Crit Public Health. 2007;17(2):113\u201321.","journal-title":"Crit Public Health"},{"issue":"12","key":"1189_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.drugpo.2015.06.006","volume":"26","author":"Y Soukup-Baljak","year":"2015","unstructured":"Soukup-Baljak Y, Greer AM, Amlani A, Sampson O, Buxton JA. Drug quality assessment practices and communication of drug alerts among people who use drugs. Int J Drug Policy. 2015;26(12):1251\u20137.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1189_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12954-022-00716-3","volume":"20","author":"I Volpe","year":"2023","unstructured":"Volpe I, Brien R, Grigg J, Tzanetis S, Crawford S, Lyons T, et al. We don\u2019t live in a harm reduction world, we live in a prohibition world\u2019: tensions arising in the design of drug alerts. Harm Reduct J. 2023;20(1):3.","journal-title":"Harm Reduct J"},{"key":"1189_CR30","doi-asserted-by":"publisher","first-page":"109427","DOI":"10.1016\/j.drugalcdep.2022.109427","volume":"235","author":"A Larnder","year":"2022","unstructured":"Larnder A, Saatchi A, Borden SA, Moa B, Gill CG, Wallace B, et al. Variability in the unregulated opioid market in the context of extreme rates of overdose. Drug Alcohol Depend. 2022;235:109427.","journal-title":"Drug Alcohol Depend"},{"key":"1189_CR31","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.drugpo.2021.103147","volume":"92","author":"MK Reed","year":"2021","unstructured":"Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. I probably got a minute: perceptions of Fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147.","journal-title":"Int J Drug Policy"},{"key":"1189_CR32","unstructured":"BCCDC. Toxic Drug & Health Alerts: Guiding Principles. Vancouver, BC: British Columbia Center for Disease Control. 2024 February 22, 2024."},{"key":"1189_CR33","unstructured":"BCCDC. Toxic Drug and Health Alerts: Recommended Practices Guide. Vancouver, BC: British Columbia Centre for Disease Control. 2024 February 22, 2024."},{"issue":"4","key":"1189_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/00914509211035487","volume":"48","author":"JJ Carroll","year":"2021","unstructured":"Carroll JJ. Auras of detection: power and knowledge in drug prohibition. Contemp Drug Probl. 2021;48(4):327\u201345.","journal-title":"Contemp Drug Probl"},{"key":"1189_CR35","doi-asserted-by":"publisher","first-page":"102845","DOI":"10.1016\/j.drugpo.2020.102845","volume":"87","author":"A Betsos","year":"2021","unstructured":"Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R. I couldn\u2019t live with killing one of my friends or anybody: A rapid ethnographic study of drug sellers\u2019 use of drug checking. Int J Drug Policy. 2021;87:102845.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1189_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12954-024-00980-5","volume":"21","author":"L Gozdzialski","year":"2024","unstructured":"Gozdzialski L, Louw R, Kielty C, Margolese A, Poarch E, Sherman M, et al. Beyond a spec: assessing heterogeneity in the unregulated opioid supply. Harm Reduct J. 2024;21(1):63.","journal-title":"Harm Reduct J"},{"key":"1189_CR37","doi-asserted-by":"publisher","first-page":"100250","DOI":"10.1016\/j.dadr.2024.100250","volume":"12","author":"B Hedden-Clayton","year":"2024","unstructured":"Hedden-Clayton B, Cochran J, Carroll JJ, Kral AH, Victor G, Comartin E, et al. If everyone knew about this, how many lives could we save? Do drug suppliers have a role in reducing overdose risk? Drug Alcohol Depend Rep. 2024;12:100250.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1189_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-020-00372-5","volume":"17","author":"G Kolla","year":"2020","unstructured":"Kolla G, Strike C. Practices of care among people who buy, use, and sell drugs in community settings. Harm Reduct J. 2020;17:1\u201312.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1189_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11243-4","volume":"21","author":"B Wallace","year":"2021","unstructured":"Wallace B, van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021;21(1):1\u201312.","journal-title":"BMC Public Health"}],"updated-by":[{"DOI":"10.1186\/s12954-025-01196-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000}}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01189-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01189-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:14:08Z","timestamp":1745205248000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01189-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01189-w","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the given and family names of Joshua Jai were incorrectly structured and it has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12954-025-01196-x","URL":"https:\/\/doi.org\/10.1186\/s12954-025-01196-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project received ethical approval from the Health Research Ethics Board at Island Health Authority (REB Number: H20-03384).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}